Civil Society Calls for Greater Engagement in Rollout of New HIV Prevention Drug Lenacapavir
Civil society organisations in Uganda have raised concerns over limited involvement in the planned rollout of a new long-acting antiretroviral drug, lenacapavir for HIV prevention, urging authorities to ensure inclusive planning and community engagement. The concerns emerged during a virtual meeting convened by HEPS-Uganda on March 17, 2026, which brought together 53 HIV prevention advocates.…